Outlook Therapeutics Inc (OTLK)

[pfelgueiras]

Outlook Therapeutics® to Present at Eyecelerator @ AAO 2022

As part of the event, Russ Trenary, President and Chief Executive Officer will present as a part of the Retina Showcase, and Terry Dagnon, Chief Operations Officer will participate in a panel presentation. Details for the presentations are as follows:

Panel: Defining Clinically Relevant Endpoints in Approval Trials

Time: 11:45 AM – 12:30 PM ET

Discussion Topic: Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.

Company Participant: Terry Dagnon, Chief Operations Officer

Company Presentation: Retina Showcases

Time: 2:46 PM – 2:51 PM ET

Presenter: Russ Trenary, President and Chief Executive Officer
SOURCE:
https://ir.outlooktherapeutics.com/node/10616/pdf